Bronx Lebanon Hospital Center   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: New York New York United States (1890)

Organization Overview

First Clinical Trial
2005
NCT00111943
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bronx-Lebanon Hospital Center | Bronx-Lebanon Hospital Center Clinical Research Site | Bronx-Lebanon Hospital Center Health Care System

Active Ingredients

Drugs in Phase 4 Trials (1)

lidocaine (xylocaine) (1 trial)

Drugs in Phase 2 Trials (3)

pf-06650833 (1 trial)

rilpivirine (edurant) (1 trial)

tenofovir (viread) (1 trial)

Drugs in Other Trials (1)

bupivacaine (Exparel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

HIV Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5